Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
Successful desensitization by glargine administration in a patient with insulin allergy: A case report
Diabetes Research and Clinical Practice, 05/18/09
Hara M et al. - The patient was a 56-year-old man with type 2 diabetes and insulin allergy. He was administered glargine, which did not produce any allergic reactions, except for a small non-pruritic wheal. Thereafter, other insulin preparation could be administered. The authors consider this the first case of successful insulin desensitization by glargine administration.
Related Articles
Comparison of Prandial AIR Inhaled Insulin Alone to Intensified Insulin Glargine Alone and to AIR Insulin Plus Intensified Insulin Glargine in Patients with Type 2 Diabetes Previously Treated with Once-Daily Insulin Glargine
Diabetes Technology & Therapeutics, 10/05/09
Relevance Score: 89%
Insulin Glargine Safety in Pregnancy: a Transplacental Transfer Study
Diabetes Care, 10/14/09
Relevance Score: 88%
Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT
Current Medical Research and Opinion, 10/22/09
Relevance Score: 84%
Evaluation of exenatide vs. insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German setting
Diabetes, Obesity and Metabolism, 10/06/09
Relevance Score: 84%
Comparison of Incidence of Acute Myocardial Infarction in Patients With Type 2 Diabetes Mellitus Following Initiation of Neutral Protamine Hagedorn Insulin Versus Insulin Glargine
The American Journal of Cardiology, 10/01/09
Relevance Score: 83%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis
Allergy and Asthma Proceedings, 12/17/09
Anti-TNF-[alpha] therapy with infliximab in spondyloarthritides
Expert Review of Clinical Immunology, 12/17/09
Immunosuppression Using the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus: Pilot Study Shows Significant Cognitive and Affective Improvement
Transplantation Proceedings, 12/17/09
Today in Endocrine...keeping you current
Receive free subspecialty "5-minute updates" via email
A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria
Annals of Allergy, Asthma, and Immunology, 12/16/09
Thymus-Blood Protein Interactions Are Highly Effective in Negative Selection and Regulatory T Cell Induction
Journal of Immunology, 12/16/09
Bim-Mediated Apoptosis Is Not Necessary for Thymic Negative Selection to Ubiquitous Self-Antigens
Journal of Immunology, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


